Effects of Training Intensity on Physical Fitness and Body Composition in Cystic Fibrosis
NCT ID: NCT05140967
Last Updated: 2025-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2021-10-15
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Partially Supervised Conditioning Program in CF
NCT01744561
A CFit Study - Acute Exercise
NCT03237767
Effects of an Individualized Exercise Program on Health-related and Skill/Performance-related fitness in CF.
NCT03518697
Fitness, Body Composition, Physical Activity and Sleep Patterns in People With Cystic Fibrosis on Modulator Therapy.
NCT05857709
Safety and Feasibility of High-intensity Interval Training Program in CF Patients
NCT04888767
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Intensity Interval Training (A)
Exercise training with intermittent bouts of high intensity
High Intensity Interval Training (HIIT)
High Intensity Interval Training
Moderate Intensity Continous Training (B)
Exercise training with constant workload
Moderate Continuous Intensity Training (MICT)
Moderate Intensity Continuous Training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Intensity Interval Training (HIIT)
High Intensity Interval Training
Moderate Continuous Intensity Training (MICT)
Moderate Intensity Continuous Training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willingness to participate in and to comply with the research project procedure,
* written informed consent of patients,
* age ≥ 18 years,
* FEV1 of pred. ≥ 40%,
* Stable condition (as indicated by absence of one or more signs: new or increased haemoptysis, increased malaise, fatigue or lethargy, temperature over 38°C, weight loss, sinus pain and a decrease in pulmonary function by 10% or more)
Exclusion Criteria
* cor pulmonale,
* musculoskeletal discomfort that makes a regular exercise training impossible,
* untreated CF-related diabetes
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fachklinik Satteldüne der DRV Nord
UNKNOWN
University of Kiel, Arbeitsbereich Sportmedizin und Trainingswissenschaften
UNKNOWN
Strandklinik St. Peter-Ording
UNKNOWN
University of Kiel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Dr. Anja Bosy-Westphal
Prof. Dr. Dr. Anja Bosy-Westphal
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anja Bosy-Westhphal, Prof, PhD, MD
Role: STUDY_CHAIR
Insitute of Human Nutrition, University of Kiel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fachklink Satteldüne der DRV Nord
Nebel / Amrum, Schleswig-Holstein, Germany
Strandklinik St. Peter-Ording
Sankt Peter-Ording, Schleswig-Holstein, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABW-2021-CF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.